Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling The Human Lab Rats Injecting Themselves with Peptides Office for Science and Society McGill University A closer look at the unapproved peptide injections promoted by influencers and celebrities king5.com